Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
NCT03767738
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Chorioretinal Vascular Disease
Interventions
DRUG:
Intravitreal Aflibercept Injection (IAI)
Sponsor
Regeneron Pharmaceuticals